| 查看: 641 | 回复: 1 | |||
jinqingxian至尊木虫 (著名写手)
有机脑力学-合成手艺学
|
[交流]
安帕来斯
|
| 谁知道安帕来斯的情况，是否允许上市？国内还是国外？销售和疗效情况如何？ |
回复此楼» 猜你喜欢
求助电子版：晶型药物研发理论与应用
已经有0人回复
-
北京大学药学院诚招药物化学/有机化学方向博士后
已经有6人回复
-
药物学论文润色/翻译怎么收费?
已经有50人回复
-
2027药学博士申请
已经有1人回复
-
亚甲基引入
已经有2人回复
-
高温加热及反应瓶材质选型
已经有1人回复
-
【交流】钆塞酸二钠：肝胆 MRI 对比剂，纯度与杂质管控的探讨
已经有0人回复
-
【交流】换季有感｜夫西地酸杂质一条有意思的连锁降解反应链
已经有0人回复
-
求助
已经有0人回复
-
[质量控制 交流] 硼替佐米质控难点，和普通多肽 API 差异分享
已经有0人回复
thecoldest
金虫 (正式写手)
- 应助: 148 (高中生)
- 金币: 1773.5
- 散金: 30
- 红花: 33
- 帖子: 588
- 在线: 116.3小时
- 虫号: 1119567
- 注册: 2010-10-11
- 专业: 药物分析
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
小木虫: 金币+0.5, 给个红包，谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
|
应该是因临床试验效果不好，被原研制方Cortex放弃了 http://www.trademarkia.com/ampakine-77965906.html ABANDONED - NO STATEMENT OF USE FILED 11/5/2012 https://en.wikipedia.org/wiki/CX-516 CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and is being developed by a collaboration of Cortex and Shire and Servier. It was researched as a treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD. CX-516 was the first ampakine compound developed by Cortex and while it showed good in vitro activity and positive results in animal tests, the human trials proved disappointing due mainly to low potency and short half-life. However, CX-516 is still widely used in animal research into the ampakine drugs and is the standard reference compound that newer, more potent drugs of this class such as farampator and CX-717 are compared to. |
2楼2016-01-03 09:48:42